These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1735 related articles for article (PubMed ID: 8425765)
21. Thymosin beta-NB is the human isoform of rat thymosin beta15. Banyard J; Hutchinson LM; Zetter BR Ann N Y Acad Sci; 2007 Sep; 1112():286-96. PubMed ID: 17567946 [TBL] [Abstract][Full Text] [Related]
22. Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts. Degen WG; Weterman MA; van Groningen JJ; Cornelissen IM; Lemmers JP; Agterbos MA; Geurts van Kessel A; Swart GW; Bloemers HP Int J Cancer; 1996 Feb; 65(4):460-5. PubMed ID: 8621228 [TBL] [Abstract][Full Text] [Related]
23. Thymosin beta 10 levels in developing human brain and its regulation by retinoic acid in the HTB-10 neuroblastoma. Hall AK; Hempstead J; Morgan JI Brain Res Mol Brain Res; 1990 Jul; 8(2):129-35. PubMed ID: 2169566 [TBL] [Abstract][Full Text] [Related]
24. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001 [TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells. Nummela P; Lammi J; Soikkeli J; Saksela O; Laakkonen P; Hölttä E Am J Pathol; 2012 Apr; 180(4):1663-74. PubMed ID: 22326753 [TBL] [Abstract][Full Text] [Related]
26. Developmental expression of mRNAs encoding thymosins beta 4 and beta 10 in rat brain and other tissues. Lin SC; Morrison-Bogorad M J Mol Neurosci; 1990; 2(1):35-44. PubMed ID: 1979498 [TBL] [Abstract][Full Text] [Related]
27. Preliminary findings on the expression of thymosin beta-10 in human breast cancer. Verghese-Nikolakaki S; Apostolikas N; Livaniou E; Ithakissios DS; Evangelatos GP Br J Cancer; 1996 Nov; 74(9):1441-4. PubMed ID: 8912542 [TBL] [Abstract][Full Text] [Related]
28. Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. de Vries TJ; Verheijen JH; de Bart AC; Weidle UH; Ruiter DJ; van Muijen GN Cancer Res; 1996 Mar; 56(6):1432-9. PubMed ID: 8640836 [TBL] [Abstract][Full Text] [Related]
29. Rosette formation in melanoma: more frequent than suspected? Pföhler C; Thirkill CE; Tilgen W Am J Dermatopathol; 2003 Aug; 25(4):360-1. PubMed ID: 12876502 [No Abstract] [Full Text] [Related]
30. Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials. Hamby CV; Mendola CE; Potla L; Stafford G; Backer JM Biochem Biophys Res Commun; 1995 Jun; 211(2):579-85. PubMed ID: 7794272 [TBL] [Abstract][Full Text] [Related]
31. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma. Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064 [TBL] [Abstract][Full Text] [Related]
32. A metastatic melanoma with an unusual immunophenotypic profile. Gao Z; Stanek A; Chen S Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440 [TBL] [Abstract][Full Text] [Related]
33. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Mihic-Probst D; Kuster A; Kilgus S; Bode-Lesniewska B; Ingold-Heppner B; Leung C; Storz M; Seifert B; Marino S; Schraml P; Dummer R; Moch H Int J Cancer; 2007 Oct; 121(8):1764-70. PubMed ID: 17597110 [TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745 [TBL] [Abstract][Full Text] [Related]
35. Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions. Maelandsmo GM; Holm R; Fodstad O; Kerbel RS; Flørenes VA Am J Pathol; 1996 Dec; 149(6):1813-22. PubMed ID: 8952518 [TBL] [Abstract][Full Text] [Related]
36. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA. Wagner SN; Wagner C; Höfler H; Atkinson MJ; Goos M Lab Invest; 1995 Aug; 73(2):229-35. PubMed ID: 7637323 [TBL] [Abstract][Full Text] [Related]
37. p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanoma. Barnhill RL; Castresana JS; Rubio MP; Martin MT; Idoate M; Vazquez JJ; Thor AD Mod Pathol; 1994 Jun; 7(5):533-5. PubMed ID: 7937717 [TBL] [Abstract][Full Text] [Related]
38. Ganglioneuroblastic differentiation in a primary cutaneous malignant melanoma. Grayson W; Maré LR Am J Dermatopathol; 2003 Feb; 25(1):40-4. PubMed ID: 12544099 [TBL] [Abstract][Full Text] [Related]
39. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Jiang H; Lin JJ; Su ZZ; Goldstein NI; Fisher PB Oncogene; 1995 Dec; 11(12):2477-86. PubMed ID: 8545104 [TBL] [Abstract][Full Text] [Related]